|
Sucralfate
Sucralfate (Carafate)
Sucralfate
(sue-KRAL-fayt)
Pregnancy Category: B
Apo-Sucralfate
Carafate
Novo-Sucralate
Nu-Sucralfate
Sulcrate
Sulcrate Suspension Plus
(Rx)
Classification:
Antiulcer drug
Action/Kinetics:
Thought to form an ulcer-adherent complex with albumin and fibrinogen at the site of the ulcer, protecting it from further damage by gastric acid. May also form a viscous, adhesive barrier on the surface of the gastric mucosa and duodenum. It adsorbs pepsin, thus inhibiting its activity. May be used in conjunction with antacids. Approximately 90% excreted in the feces. Duration: 5 hr.
Uses:
Short-term treatment (up to 8 weeks) of active duodenal ulcers. Maintenance for duodenal ulcer at decreased dosage after healing of acute ulcers. Investigational: Hasten healing of gastric ulcers, chronic treatment of gastric ulcers. Treatment of reflux and peptic esophagitis. Treatment of aspirin- and NSAID-induced GI symptoms; prevention of stress ulcers and GI bleeding in critically ill clients. The suspension has been used to treat oral and esophageal ulcers due to chemotherapy, radiation, or sclerotherapy.
Note: Even though healing of ulcers may result, the frequency or severity of subsequent attacks is not altered.
Special Concerns:
Safety for use in children and during lactation has not been fully established. A successful course resulting in healing of ulcers will not alter posthealing frequency or severity of duodenal ulceration.
Side Effects:
GI: Constipation (most common); also, N&V;, diarrhea, indigestion, flatulence, dry mouth, gastric discomfort. Hypersensitivity: Urticaria, angioedema, respiratory difficulty rhinitis. Miscellaneous: Back pain, dizziness, sleepiness, vertigo, rash, pruritus, facial swelling, laryngospasm.
Drug Interactions:
- Antacids containing aluminum /
Total body burden of aluminum
- Anticoagulants /
Hypoprothrombinemic effect of warfarin
- Cimetidine /
Absorption of cimetidine due to binding to sucralfate
- Ciprofloxacin /
Absorption of ciprofloxacin due to binding to sucralfate
- Digoxin /
Absorption of digoxin due to binding to sucralfate
- Ketoconazole /
Bioavailability of ketoconazole
- Norfloxacin /
Absorption of norfloxacin due to binding to sucralfate
- Phenytoin /
Absorption of phenytoin due to binding to sucralfate
- Quinidine /
Quinidine levels effect
- Ranitidine /
Absorption of ranitidine due to binding to sucralfate
- Tetracycline /
Absorption of tetracycline due to binding to sucralfate
- Theophylline /
Absorption of theophylline due to binding to sucralfate
How Supplied:
Suspension: 1 g/10 mL; Tablet: 1 g
Dosage
•Suspension, Tablets
Adults: usual: 1 g q.i.d. (10 mL of the suspension) 1 hr before meals and at bedtime (it may also be taken 2 hr after meals). Take for 4-8 weeks unless X-ray films or endoscopy have indicated significant healing. Maintenance (tablets only): 1 g b.i.d. |